Azenta, Inc. ( (AZTA) ) has released its Q3 earnings. Here is a breakdown of the information Azenta, Inc. presented to its investors.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Azenta, Inc. is a global leader in life sciences solutions, offering comprehensive cold-chain sample management and multiomics services to accelerate drug development and clinical research for top pharmaceutical, biotech, academic, and healthcare institutions worldwide. Headquartered in Burlington, Massachusetts, Azenta operates across North America, Europe, and Asia.
In its third quarter fiscal 2025 earnings report, Azenta, Inc. maintained steady revenue from continuing operations at $144 million, despite a challenging macroeconomic environment. The company highlighted its operational turnaround efforts, focusing on disciplined cost management and margin expansion, while reiterating its full-year fiscal 2025 guidance.
Key financial metrics showed a mixed performance with a slight decline in Sample Management Solutions revenue by 4% year-over-year, countered by a 4% increase in Multiomics revenue. The company’s adjusted EBITDA for continuing operations improved by 27% year-over-year, reaching $18 million, with an adjusted EBITDA margin of 12.3%. Non-GAAP diluted EPS from continuing operations also rose to $0.19, reflecting a 31% increase from the previous year.
Despite an operating loss of $0.7 million, Azenta achieved a gross margin of 47.1%, up 170 basis points year-over-year, driven by a favorable sales mix and improved cost execution. The company ended the quarter with a robust cash position of $565 million, supporting its strategic initiatives and future growth opportunities.
Looking ahead, Azenta’s management remains confident in achieving its full-year goals, with expectations of organic revenue growth between 3% to 5% and an adjusted EBITDA margin expansion of approximately 300 basis points. The company continues to build a strong foundation to support its long-term strategy, positioning itself to capitalize on future market opportunities.